podcast
details
.com
Print
Share
Look for any podcast host, guest or anyone
Search
Showing episodes and shows of
Ulrich Mansmann
Shows
Vorsicht, Kunde!
Vorsicht, Kunde! – Ungeplante Preiserhöhung
Der Verbraucherschutz-Podcast der c’t In der sechsten Episode des c’t-Verbraucherschutz-Podcast „Vorsicht, Kunde!“ geht es um überraschende Preiserhöhungen während eines laufenden Vertrags. Ulrike Kuhlmann und Urs Mansmann aus der c’t-Redaktion und Rechtsanwalt Niklas Mühleis klären dazu folgende Fragen: Welche Rechte habt ihr als Kunden bei einer außerplanmäßigen Preiserhöhung? Wie könnt ihr euch gegen solche Preiserhöhungen wehren? Und wie solltet ihr reagieren, wenn der Vertragspartner die zusätzlichen Gebühren einfach abbucht. Etwaige Vertragsänderungen hat das Telekommunikationsgesetz klar umrissen. Da jede Preiserhöhung zugleich eine Vertragsänderung ist...
2024-05-24
37 min
IM Journal Club
Network Meta-Analysis w/ Dr. Ulrich Mansmann
We are proud to bring you our first methods primer! We will consider methods primers whenever we cover a study with a more an usual or slightly more complicated methods. Last week's network-meta-analysis on DVT prophylaxis with Dr. Tony Breu should certainly qualify!Meta-analysis (both the classical one and the network type) can provide a quantitative synthesis of controlled studies (e.g., randomized controlled trials).NETWORK meta-analysis can help with two additional things:Through indirect treatment comparison (or a combination of indirect and direct comparison) it can increase your...
2022-11-04
18 min
IM Journal Club
Modeling COVID-19 w/ Dr. Ulrich Mansmann
Since the onset of the COVID-19 pandemic, we have come a long way to understand the complex and changing dynamics of the severe acute respiratory syndrome caused by this virus (SARS-CoV-2).Mathematical modeling and quantitative analysis of empirical data played a pivotal role to answer the emerging questions as the pandemic unfolds and to better understand and control the pandemic. Three articles are presented that describe and critique the role of modeling during the pandemic.Speaker: Ulrich Mansmann, Ph.D. (LMU Munich, Germany)0:00 Intro2:12 Why model COVID-19?5:55...
2022-10-27
42 min
IM Journal Club
Welcome
Do you also find it hard to follow the medical literature?Newsletters with tables of contents are hard to get through after having written all your notes and maybe having done a chart dissection.Welcome to IM Journal Club!Our mission: to guide you through some of the most interesting internal medicine studies published in the last few weeks and months that you WOULD have liked to or SHOULD have heard aboutTarget groups: physicians and other clinicians in general internal or family medicine – hospital medicine and primary ca...
2022-10-27
02 min
re:publica 19 - Science & Technology
Dr. Algorithmus – Das berechnete Gesundheitsrisiko
Im Gesundheitsbereich werden große Erwartungen an die Nutzung von Big Data, Algorithmen und Machine Learning gestellt. Ein Beispiel dafür sind Risikorechner, mit denen das persönliche Krankheitsrisiko bestimmt werden kann. Sie sollen Gesunden, Kranken und ÄrztInnen Orientierung geben und Entscheidungen erleichtern. Die Tools sind komplex, aber verlockend einfach zu bedienen. Zeit, sie zu hinterfragen. Brigitte StrahwaldUlrich MansmannOnline sind zahllose Tools verfügbar, mit denen das individuelle Risiko für Herzinfarkt, Krebs oder sogar eine verkürzte Lebenserwartung mit wenigen Mausklicks berechnet werden kann. Aber lässt sich die eigene gesundheitliche Zukunft so einfach bestimmen? Für die Nu...
2019-05-08
33 min
ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
Penalization Theory and Practice for Cox Models
ISCB 2013
2019-04-18
29 min
ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
Biomarker-based phase III clinical trial: Real-world experiences
ISCB 2013
2019-04-18
23 min
ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
Estimating effects of time-varying treatments: pitfalls and opportunities
ISCB 2013
2019-04-18
30 min
ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
Evaluating and addressing consistency of the evidence in a network metaanalysis
ISCB 2013
2019-04-18
19 min
ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
Recent developments in updating and extending risk prediction models, the European Randomized Study of Prostate Cancer Risk Calculator
ISCB 2013
2019-04-18
29 min
ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
From model building to validation and back: a plea for robustness
ISCB 2013
2019-04-18
57 min
ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
Using network meta-analysis for decision making
ISCB 2013
2019-04-18
22 min
ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
Joint longitudinal survival models for prediction of prostate cancer recurrence following radiotherapy
ISCB 2013
2019-04-18
23 min
ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
Adaptive designs for confirmatory clinical trials with treatment selection
ISCB 2013
2019-04-18
19 min
ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
Recent developments in updating and extending risk prediction models, the Prostate Cancer Prevention Trial Calculator
contribution and discussion
2013-08-29
47 min
ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
Gene signatures as treatment modifiers in clinical trial
ISCB 2013
2013-08-29
24 min
ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
Biomarker-based phase II trial designs
ISCB 2013
2013-08-29
22 min
ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
Utility-Based Dose-Finding with Ordinal Toxicity and Efficacy
ISCB 2013
2013-08-29
18 min
ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
Causal search in high-dimensional settings
ISCB 2013
2013-08-29
25 min
ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
Assessing mediation through multiple pathways using natural effect models
ISCB 2013
2013-08-28
23 min
ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
The meta-analytic approach to validation of surrogate endpoints
ISCB 2013
2013-08-28
22 min
ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
TBD (on meta-regression)
ISCB 2013
2013-08-28
19 min
ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
Two folklores: ridge regression versus the lasso
ISCB 2013
2013-08-27
28 min
ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
Purposeful penalization of likelihood in small samples
ISCB 2013
2013-08-27
27 min